{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:45:33Z","timestamp":1789469133217,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["82460375"],"award-info":[{"award-number":["82460375"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guizhou Science and Technology Support Program","award":["2025-General-121"],"award-info":[{"award-number":["2025-General-121"]}]},{"name":"Guizhou Provincial Health Commission Science and Technology Fund Project","award":["2025GZWJKJXM0453"],"award-info":[{"award-number":["2025GZWJKJXM0453"]}]},{"name":"Science and Technology Program for Social Development of Zhuhai","award":["2420004000107"],"award-info":[{"award-number":["2420004000107"]}]},{"name":"The program for training innovation and entrepreneurship for undergraduates of Zunyi Medical University","award":["ZHCX2023009"],"award-info":[{"award-number":["ZHCX2023009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07133-7","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:55:01Z","timestamp":1781664901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends and projections of high body mass index-associated non-hodgkin lymphoma burden (1990\u20132040): A global burden of disease 2021 analysis"],"prefix":"10.1007","volume":"105","author":[{"given":"Yuhao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"1","key":"7133_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/ajh.26744","volume":"98","author":"C Radkiewicz","year":"2023","unstructured":"Radkiewicz C et al (2023) Sex differences in lymphoma incidence and mortality by subtype: A population-based study. Am J Hematol 98(1):23\u201330","journal-title":"Am J Hematol"},{"issue":"1","key":"7133_CR2","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1186\/s12889-025-22376-1","volume":"25","author":"S Wang","year":"2025","unstructured":"Wang S et al (2025) Trends and projections of Non-Hodgkin lymphoma burden (1990\u20132040): a global burden of disease 2021 analysis. BMC Public Health 25(1):1223","journal-title":"BMC Public Health"},{"issue":"3","key":"7133_CR3","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"7133_CR4","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.4103\/jfmpc.jfmpc_1037_19","volume":"9","author":"R Singh","year":"2020","unstructured":"Singh R et al (2020) Non-Hodgkin\u2019s lymphoma: A review. J Family Med Prim Care 9(4):1834\u20131840","journal-title":"J Family Med Prim Care"},{"key":"7133_CR5","doi-asserted-by":"crossref","unstructured":"Thandra KC et al (2021) Epidemiology of Non-Hodgkin\u2019s Lymphoma. Med Sci (Basel), 9(1):5","DOI":"10.3390\/medsci9010005"},{"issue":"4","key":"7133_CR6","first-page":"226","volume":"2","author":"J Luo","year":"2022","unstructured":"Luo J et al (2022) Etiology of non-Hodgkin lymphoma: A review from epidemiologic studies. J Natl Cancer Cent 2(4):226\u2013234","journal-title":"J Natl Cancer Cent"},{"issue":"2","key":"7133_CR7","doi-asserted-by":"publisher","first-page":"e0297140","DOI":"10.1371\/journal.pone.0297140","volume":"19","author":"M Sarpa","year":"2024","unstructured":"Sarpa M et al (2024) Investigation of occupational risk factors for the development of non-Hodgkin\u2019s lymphoma in adults: A hospital-based case-control study. PLoS ONE 19(2):e0297140","journal-title":"PLoS ONE"},{"issue":"4","key":"7133_CR8","first-page":"170","volume":"20","author":"F Mulita","year":"2021","unstructured":"Mulita F et al (2021) Long-term nutritional deficiencies following sleeve gastrectomy: a 6-year single-centre retrospective study. Prz Menopauzalny 20(4):170\u2013176","journal-title":"Prz Menopauzalny"},{"key":"7133_CR9","unstructured":"Weir CB, Jan A (2025) BMI Classification Percentile And Cut Off Points, in StatPearls. StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC.: Treasure Island (FL)"},{"key":"7133_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-3-319-42542-9_13","volume":"208","author":"AG Renehan","year":"2016","unstructured":"Renehan AG, Soerjomataram I (2016) Obesity as an Avoidable Cause of Cancer (Attributable Risks). Recent Results Cancer Res 208:243\u2013256","journal-title":"Recent Results Cancer Res"},{"issue":"23","key":"7133_CR11","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1002\/cncr.35536","volume":"130","author":"C Zeng","year":"2024","unstructured":"Zeng C et al (2024) Effect of body mass index on the prognosis of children and adolescents with high-grade mature B-cell non-Hodgkin lymphoma. Cancer 130(23):4109\u20134117","journal-title":"Cancer"},{"issue":"1","key":"7133_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12916-020-01877-3","volume":"19","author":"M Recalde","year":"2021","unstructured":"Recalde M et al (2021) Body mass index and waist circumference in relation to the risk of 26 types of cancer: a prospective cohort study of 3.5 million adults in Spain. BMC Med 19(1):10","journal-title":"BMC Med"},{"issue":"7","key":"7133_CR13","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/sj.bjc.6602762","volume":"93","author":"EV Willett","year":"2005","unstructured":"Willett EV et al (2005) Non-Hodgkin\u2019s lymphoma, obesity and energy homeostasis polymorphisms. Br J Cancer 93(7):811\u2013816","journal-title":"Br J Cancer"},{"issue":"7","key":"7133_CR14","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1002\/ijc.22762","volume":"121","author":"SC Larsson","year":"2007","unstructured":"Larsson SC, Wolk A (2007) Obesity and risk of non-Hodgkin\u2019s lymphoma: a meta-analysis. Int J Cancer 121(7):1564\u20131570","journal-title":"Int J Cancer"},{"issue":"12","key":"7133_CR15","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1002\/cncr.25114","volume":"116","author":"SM Geyer","year":"2010","unstructured":"Geyer SM et al (2010) Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study. Cancer 116(12):2993\u20133000","journal-title":"Cancer"},{"issue":"3","key":"7133_CR16","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1158\/1055-9965.EPI-06-1081","volume":"16","author":"CF Skibola","year":"2007","unstructured":"Skibola CF (2007) Obesity, diet and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16(3):392\u2013395","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"7133_CR17","doi-asserted-by":"publisher","first-page":"910641","DOI":"10.3389\/fpubh.2022.910641","volume":"10","author":"HM Ren","year":"2022","unstructured":"Ren HM et al (2022) Global, Regional, and National Burden of Cancer in Children Younger Than 5 Years, 1990\u20132019: Analysis of the Global Burden of Disease Study 2019. Front Public Health 10:910641","journal-title":"Front Public Health"},{"key":"7133_CR18","doi-asserted-by":"publisher","first-page":"102758","DOI":"10.1016\/j.eclinm.2024.102758","volume":"75","author":"XY Li","year":"2024","unstructured":"Li XY et al (2024) Global, regional, and national burden of ischemic stroke, 1990\u20132021: an analysis of data from the global burden of disease study 2021. EClinicalMedicine 75:102758","journal-title":"EClinicalMedicine"},{"key":"7133_CR19","doi-asserted-by":"crossref","unstructured":"Yang C et al (2025) Global, regional, and national burdens of heart failure in adolescents and young adults aged 10\u201324 years from 1990 to 2021: an analysis of data from the Global Burden of Disease Study 2021, vol 79. EClinicalMedicine, p 102998","DOI":"10.1016\/j.eclinm.2024.102998"},{"key":"7133_CR20","doi-asserted-by":"crossref","unstructured":"Ferrari AJ et al (2024) Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403(10440):2133\u20132161","DOI":"10.1016\/S0140-6736(24)00757-8"},{"issue":"5","key":"7133_CR21","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/jre.13337","volume":"59","author":"GG Nascimento","year":"2024","unstructured":"Nascimento GG, Alves-Costa S, Romandini M (2024) Burden of severe periodontitis and edentulism in 2021, with projections up to 2050: The Global Burden of Disease 2021 study. J Periodontal Res 59(5):823\u2013867","journal-title":"J Periodontal Res"},{"issue":"1","key":"7133_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s10194-024-01798-z","volume":"25","author":"J Cen","year":"2024","unstructured":"Cen J et al (2024) Global, regional, and national burden and trends of migraine among women of childbearing age from 1990 to 2021: insights from the Global Burden of Disease Study 2021. J Headache Pain 25(1):96","journal-title":"J Headache Pain"},{"key":"7133_CR23","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ijcard.2023.04.060","volume":"384","author":"L Zhang","year":"2023","unstructured":"Zhang L et al (2023) Spatiotemporal trends in global burden of rheumatic heart disease and associated risk factors from 1990 to 2019. Int J Cardiol 384:100\u2013106","journal-title":"Int J Cardiol"},{"key":"7133_CR24","doi-asserted-by":"publisher","first-page":"1303531","DOI":"10.3389\/fneur.2023.1303531","volume":"14","author":"Y Shu","year":"2023","unstructured":"Shu Y et al (2023) The burden of epilepsy in the People\u2019s Republic of China from 1990 to 2019: epidemiological trends and comparison with the global burden of epilepsy. Front Neurol 14:1303531","journal-title":"Front Neurol"},{"key":"7133_CR25","doi-asserted-by":"publisher","first-page":"1617613","DOI":"10.3389\/fonc.2025.1617613","volume":"15","author":"J Jiang","year":"2025","unstructured":"Jiang J, Xia Z, Yao W (2025) Global, regional, and national larynx cancer burden and health inequality analysis from 1990 to 2021 with a prediction from 2022 to 2040. Front Oncol 15:1617613","journal-title":"Front Oncol"},{"issue":"4","key":"7133_CR26","doi-asserted-by":"publisher","first-page":"e0013017","DOI":"10.1371\/journal.pntd.0013017","volume":"19","author":"H Zhao","year":"2025","unstructured":"Zhao H, Xu T, Shen H (2025) Global, regional, and national disability-adjusted life years and prevalence of lymphatic filariasis from 1990 to 2021: A trend and health inequality analysis based on the global burden of disease study 2021. PLoS Negl Trop Dis 19(4):e0013017","journal-title":"PLoS Negl Trop Dis"},{"key":"7133_CR27","doi-asserted-by":"publisher","first-page":"04131","DOI":"10.7189\/jogh.14.04131","volume":"14","author":"Y Gong","year":"2024","unstructured":"Gong Y et al (2024) Thyroid cancer trends in China and its comparative analysis with G20 countries: Projections for 2020\u20132040. J Glob Health 14:04131","journal-title":"J Glob Health"},{"issue":"2","key":"7133_CR28","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/ckj\/sfac218","volume":"16","author":"Y Li","year":"2023","unstructured":"Li Y et al (2023) Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019. Clin Kidney J 16(2):312\u2013321","journal-title":"Clin Kidney J"},{"issue":"7","key":"7133_CR29","doi-asserted-by":"publisher","first-page":"e0306991","DOI":"10.1371\/journal.pone.0306991","volume":"19","author":"J Zhang","year":"2024","unstructured":"Zhang J et al (2024) Global burden and epidemiological prediction of polycystic ovary syndrome from 1990 to 2019: A systematic analysis from the Global Burden of Disease Study 2019. PLoS ONE 19(7):e0306991","journal-title":"PLoS ONE"},{"issue":"1","key":"7133_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12911-021-01501-1","volume":"21","author":"SC Johnson","year":"2021","unstructured":"Johnson SC et al (2021) Public health utility of cause of death data: applying empirical algorithms to improve data quality. BMC Med Inf Decis Mak 21(1):175","journal-title":"BMC Med Inf Decis Mak"},{"key":"7133_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.critrevonc.2018.05.018","volume":"129","author":"K Hidayat","year":"2018","unstructured":"Hidayat K, Li HJ, Shi BM (2018) Anthropometric factors and non-Hodgkin\u2019s lymphoma risk: systematic review and meta-analysis of prospective studies. Crit Rev Oncol Hematol 129:113\u2013123","journal-title":"Crit Rev Oncol Hematol"},{"key":"7133_CR32","doi-asserted-by":"publisher","first-page":"1059914","DOI":"10.3389\/fonc.2023.1059914","volume":"13","author":"Y Chu","year":"2023","unstructured":"Chu Y et al (2023) The epidemiological patterns of non-Hodgkin lymphoma: global estimates of disease burden, risk factors, and temporal trends. Front Oncol 13:1059914","journal-title":"Front Oncol"},{"issue":"11","key":"7133_CR33","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s10552-014-0447-6","volume":"25","author":"QJ Leo","year":"2014","unstructured":"Leo QJ et al (2014) Obesity and non-Hodgkin lymphoma survival in an ethnically diverse population: the Multiethnic Cohort study. Cancer Causes Control 25(11):1449\u20131459","journal-title":"Cancer Causes Control"},{"key":"7133_CR34","unstructured":"Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. et al (2018) Lancet 392(10159):p1923\u20131994"},{"key":"7133_CR35","unstructured":"Michael B et al (2024) Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403(10440):2162\u20132203"},{"issue":"3","key":"7133_CR36","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s00277-025-06261-w","volume":"104","author":"S Tang","year":"2025","unstructured":"Tang S et al (2025) Global, regional and national temporal trends in incidence and mortality of non-Hodgkin lymphoma from 1992 to 2021: an age-period-cohort analysis. Ann Hematol 104(3):1679\u20131696","journal-title":"Ann Hematol"},{"issue":"1","key":"7133_CR37","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1186\/s12889-021-10692-1","volume":"21","author":"VM Oguoma","year":"2021","unstructured":"Oguoma VM et al (2021) Prevalence of overweight and obesity, and associations with socio-demographic factors in Kuwait. BMC Public Health 21(1):667","journal-title":"BMC Public Health"},{"issue":"10542","key":"7133_CR38","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/S0140-6736(26)00042-5","volume":"407","author":"GMA Wyper","year":"2026","unstructured":"Wyper GMA, Cuschieri S, Devleesschauwer B (2026) The plight of the Monaco microstate in the GBD 2023 study. Lancet 407(10542):1915\u20131916","journal-title":"Lancet"},{"issue":"1","key":"7133_CR39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40164-025-00684-x","volume":"14","author":"T Pan","year":"2025","unstructured":"Pan T et al (2025) Global burden and trends of hematologic malignancies based on Global Cancer Observatory 2022 and Global Burden of Disease 2021. Exp Hematol Oncol 14(1):98","journal-title":"Exp Hematol Oncol"},{"key":"7133_CR40","unstructured":"Dana B et al (2024) Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Public Health 9(10):e729\u2013e744"},{"issue":"11","key":"7133_CR41","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1111\/dom.15238","volume":"25","author":"K Chen","year":"2023","unstructured":"Chen K et al (2023) Prevalence of obesity and associated complications in China: A cross-sectional, real-world study in 15.8 million adults. Diabetes Obes Metab 25(11):3390\u20133399","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"7133_CR42","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1177\/10815589241262003","volume":"72","author":"JY Tan","year":"2024","unstructured":"Tan JY et al (2024) Non-Hodgkin lymphoma mortality disparities across different sexes, races, and geographic locations. J Investig Med 72(7):723\u2013729","journal-title":"J Investig Med"},{"issue":"3\u20135","key":"7133_CR43","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0960-0760(03)00360-1","volume":"86","author":"ER Simpson","year":"2003","unstructured":"Simpson ER (2003) Sources of estrogen and their importance. J Steroid Biochem Mol Biol 86(3\u20135):225\u2013230","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3 Suppl","key":"7133_CR44","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.1067\/mjd.2001.117432","volume":"45","author":"LR Nelson","year":"2001","unstructured":"Nelson LR, Bulun SE (2001) Estrogen production and action. J Am Acad Dermatol 45(3 Suppl):S116\u2013S124","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"7133_CR45","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1182\/blood.V95.6.2059","volume":"95","author":"KL Medina","year":"2000","unstructured":"Medina KL, Strasser A, Kincade PW (2000) Estrogen influences the differentiation, proliferation, and survival of early B-lineage precursors. Blood 95(6):2059\u20132067","journal-title":"Blood"},{"issue":"2","key":"7133_CR46","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1084\/jem.180.2.717","volume":"180","author":"G Smithson","year":"1994","unstructured":"Smithson G et al (1994) Increased B lymphopoiesis in genetically sex steroid-deficient hypogonadal (hpg) mice. J Exp Med 180(2):717\u2013720","journal-title":"J Exp Med"},{"key":"7133_CR47","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fonc.2018.00103","volume":"8","author":"HD Hosgood","year":"2018","unstructured":"Hosgood HD et al (2018) The Relation of Obesity-Related Hormonal and Cytokine Levels With Multiple Myeloma and Non-Hodgkin Lymphoma. Front Oncol 8:103","journal-title":"Front Oncol"},{"issue":"1","key":"7133_CR48","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s43856-025-00838-2","volume":"5","author":"C Ge","year":"2025","unstructured":"Ge C et al (2025) The global burden of high BMI among adolescents between 1990 and 2021. Commun Med (Lond) 5(1):125","journal-title":"Commun Med (Lond)"},{"key":"7133_CR49","doi-asserted-by":"crossref","unstructured":"Karchynskaya V et al (2020) Is BMI a Valid Indicator of Overweight and Obesity for Adolescents? Int J Environ Res Public Health 17(13):4815","DOI":"10.3390\/ijerph17134815"},{"key":"7133_CR50","doi-asserted-by":"crossref","unstructured":"Mulita F et al (2022) A Smarter Health through the Internet of Surgical Things. Sens (Basel) 22(12):4577","DOI":"10.3390\/s22124577"},{"key":"7133_CR51","doi-asserted-by":"publisher","first-page":"738693","DOI":"10.3389\/fmed.2021.738693","volume":"8","author":"W Cai","year":"2021","unstructured":"Cai W et al (2021) Trends Analysis of Non-Hodgkin Lymphoma at the National, Regional, and Global Level, 1990\u20132019: Results From the Global Burden of Disease Study 2019. Front Med (Lausanne) 8:738693","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"7133_CR52","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3109\/08880018.2014.939793","volume":"31","author":"X Sun","year":"2014","unstructured":"Sun X et al (2014) Treatment outcome of Chinese children with anaplastic large cell lymphoma by using a modified B-NHL-BFM-90 protocol. Pediatr Hematol Oncol 31(6):518\u2013527","journal-title":"Pediatr Hematol Oncol"},{"key":"7133_CR53","doi-asserted-by":"crossref","unstructured":"Mulita A et al (2025) Benefits from (18)F-FDG PET-CT-Based Radiotherapy Planning in Stage III Non-Small-Cell Lung Cancer: A Prospective Single-Center Study. Cancers (Basel) 17(12):1969","DOI":"10.3390\/cancers17121969"},{"issue":"1","key":"7133_CR54","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13045-019-0799-1","volume":"12","author":"L Zhou","year":"2019","unstructured":"Zhou L et al (2019) Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study. J Hematol Oncol 12(1):107","journal-title":"J Hematol Oncol"},{"issue":"6","key":"7133_CR55","first-page":"666","volume":"60","author":"C R\u00edos-Reyna","year":"2022","unstructured":"R\u00edos-Reyna C et al (2022) [Policies and strategies to combat obesity in Latin America]. Rev Med Inst Mex Seguro Soc 60(6):666\u2013674","journal-title":"Rev Med Inst Mex Seguro Soc"},{"issue":"6","key":"7133_CR56","doi-asserted-by":"publisher","first-page":"e027962","DOI":"10.1136\/bmjopen-2018-027962","volume":"9","author":"CL Miller","year":"2019","unstructured":"Miller CL et al (2019) Are Australians ready for warning labels, marketing bans and sugary drink taxes? Two cross-sectional surveys measuring support for policy responses to sugar-sweetened beverages. BMJ Open 9(6):e027962","journal-title":"BMJ Open"},{"issue":"5","key":"7133_CR57","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1470-2045(13)70048-2","volume":"14","author":"PE Goss","year":"2013","unstructured":"Goss PE et al (2013) Planning cancer control in Latin America and the Caribbean. Lancet Oncol 14(5):391\u2013436","journal-title":"Lancet Oncol"},{"issue":"14","key":"7133_CR58","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S1470-2045(15)00218-1","volume":"16","author":"K Strasser-Weippl","year":"2015","unstructured":"Strasser-Weippl K et al (2015) Progress and remaining challenges for cancer control in Latin America and the Caribbean. Lancet Oncol 16(14):1405\u20131438","journal-title":"Lancet Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07133-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07133-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07133-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:43:06Z","timestamp":1789465386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07133-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":58,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["7133"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07133-7","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study utilized publicly available, deidentified data from the Global Burden of Disease Study 2021. The requirement for written informed consent was waived in accordance with institutional and international ethical guidelines. The study protocol, including this waiver, was reviewed and approved by the Ethics Committee of the Fifth Affiliated Hospital (Zhuhai) of Zunyi Medical University (approval number: 2025KY0028).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"392"}}